The First Case of B-lymphoblastic Leukemia Associated With t(7;8)(q34;p11.2) and FGFR1 Rearrangement

참고문헌 (10)

1. Arber DA, "The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia", Blood, 127, pp.2391~2405 (2016)
2. Huret JL, "FGFR1(fibroblast growth factor receptor 1)", Atlas of Genetics and Cytogenetics in Oncology and Haematology, 13, pp.821~840 (2009)
3. Macdonald D, "The 8p11 myeloproliferative syndrome : a distinct clinical entity caused by constitutive activation of FGFR1", Acta Haematol, 107, pp.101~107 (2002)
4. Bain BJ, "WHO classification of tumours of haematopoietic and lymphoid tissues", pp.72~79 (2017), International Agency for Research on Cancer
5. Jackson CC, "8p11 myeloproliferative syndrome : a review", Hum Pathol, 41, pp.461~476 (2010)
6. Belloni E, "8p11 myeloproliferative syndrome with a novel t(7;8)translocation leading to fusion of the FGFR1 and TIF1 genes", Genes, Chromosomes and Cancer, 42, pp.320~325 (2005)
7. isoxazol-5-amine derivatives as potent and selective TRIM24 bromodomain inhibitors with potential anti-cancer activities, "Bioorg Chem", 2020, 103424~
8. Huret JL, "TRIM24(tripartite motif-containing 24)", Atlas of Genetics and Cytogenetics in Oncology and Haematology, 11, pp.111~112 (2007)
9. McAvera RM, "TIF1 proteins in genome stability and cancer", Cancers(Basel), 12, pp.2094~ (2020)
10. Hughes T, "Monitoring CML patients responding to treatment with tyrosine kinase inhibitors : review and recommendations for harmonizing current methodology for detecting bcr-abl transcripts and kinase domain mutations and for expressing results", Blood, 108, pp.28~37 (2006)

관련 논문AI추천